Floersheim, Germany

Heinz-Peter Rebenstock

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz-Peter Rebenstock. Retrieved from https://idiyas.com/inventor/heinz-peter-rebenstock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Heinz-Peter Rebenstock in the Field of Imidazol Derivatives

Introduction

Heinz-Peter Rebenstock, a notable inventor based in Flörsheim, Germany, has made significant contributions to the field of pharmaceuticals. His innovative work especially focuses on the synthesis of chemical compounds, which are essential for various applications in medicine.

Latest Patents

Rebenstock holds a patent for a "Method for producing S-alkyl(aryl)-substituted imidazol derivatives." This invention is crucial for the development of new therapeutic agents, highlighting his role in advancing pharmaceutical science.

Career Highlights

Employed at Aventis Pharma Deutschland GmbH, Rebenstock has been part of a company renowned for its commitment to research and development in the pharmaceutical industry. His work has helped pave the way for new drug formulations that can improve patient outcomes.

Collaborations

Throughout his career, Heinz-Peter Rebenstock has collaborated with notable colleagues, including Bernd Napierski and Wolfgang Holla. These partnerships have enabled the sharing of expertise and ideas, further enhancing the innovation landscape within the company.

Conclusion

Heinz-Peter Rebenstock's single patent exemplifies the blend of creativity and scientific knowledge essential for breakthroughs in drug development. His contributions at Aventis Pharma Deutschland GmbH signify the critical role that inventors play in shaping the future of healthcare through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…